saikosaponin d has been researched along with Chronic Kidney Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Deng, Z; Huang, M; She, M; Wang, D; Yan, Y; Yang, Y; Zhang, M; Zhou, L | 1 |
| Chen, C; Chen, X; Hu, X | 1 |
2 other study(ies) available for saikosaponin d and Chronic Kidney Diseases
| Article | Year |
|---|---|
Saikosaponin A and D attenuate skeletal muscle atrophy in chronic kidney disease by reducing oxidative stress through activation of PI3K/AKT/Nrf2 pathway.
Topics: Animals; Antioxidants; Mice; Muscle Fibers, Skeletal; Muscle, Skeletal; Muscular Atrophy; NF-E2-Related Factor 2; Oxidation-Reduction; Oxidative Stress; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Quality of Life; Renal Insufficiency, Chronic | 2023 |
Saikosaponin A protects against uremic toxin indole‑3 acetic acid‑induced damage to the myocardium.
Topics: Acetates; Animals; Indoles; Mice; Myocardium; Myocytes, Cardiac; Renal Insufficiency, Chronic; Signal Transduction; Uremic Toxins | 2023 |